Confirmed Virologic Failure at or Prior to Week 48 [clinicaltrials_resource:NCT00608569/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Confirmed Virologic Failure at or Prior to Week 48 [clinicaltrials_resource:NCT00608569/outcome/1]
Bio2RDF identifier
NCT00608569/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00608569/outcome/1
analysis [clinicaltrials_vocabulary:analysis]
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
Only the 257 eligible particip ...... ence to LPV/rtv was collected.
Two hundred fifty seven eligib ...... reated analysis was performed.
Two hundred fifty seven eligib ...... treat analysis was performed.
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
52 weeks since randomization
At Weeks 4, 12, 24, 36, and 48
At or prior to Week 24
At or prior to Week 48
At week 4, 12, 24, 36, and 48
At weeks 4, 8, 12, 24, 36, 48 and 52
type [clinicaltrials_vocabulary:type]
alternate
Confirmed Virologic Failure at or Prior to Week 48
@en
identifier
clinicaltrials_resource:NCT00608569/outcome/1
title
Confirmed virologic failure wa ...... prior to week 48 was reported.
@en
type
label
Confirmed Virologic Failure at ...... esource:NCT00608569/outcome/1]
@en